The Government must accompany its decision to reintroduce
the sale of pseudoephedrine into community pharmacies with a
real-time monitoring system to ensure patient and pharmacy
safety, Pharmaceutical Society of New Zealand (PSNZ)
President Rhiannon Braund said today.
“Australia
already has these real-time monitoring systems and New
Zealand needs them too for restricted drugs like
pseudoephedrine where people may seek supplies from multiple
pharmacies.
“We want a system that provides
information to doctors and pharmacists about a patient’s
history and use of restricted medicines when they are
considering prescribing or dispensing this
medicine.
“We want patients to be required to
undergo a conversation with a pharmacist if they want to
access this medicine – the same way in which people must
when accessing the emergency contraceptive pill or other
restricted medicines.
“People do need education
around this medicine and interaction with a pharmacist is a
critical time to let people know about the potential
addictive nature of pseudoephedrine,” says Professor
Braund.
The Society also wants to see the Government
provide pharmacies access to similar funding that was made
available to dairy owners, liquor stores and petrol stations
to deal with ram raids.
“Pharmacies stocking
pseudoephedrine could be at increased risk from being the
target of break-ins and armed robberies. We want pharmacists
to have access to the same crime security measures other
businesses have.
“The security measures are about
keeping the public and pharmacists safe. Having a monitoring
system and security fund in place before pseudoephedrine is
made available over the counter should be a priority for the
Government.
“The Society is happy to take part in
consultation of how this policy will
work.”
Advertisement – scroll to continue reading
© Scoop Media
Advertisement – scroll to continue reading



















Discussion about this post